Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	140.92B +5.7%
Revenue (ttm)	19.76B +23.5%
Net Income	1.26B +40.6%
EPS	3.96 +28.5%
Shares Out	316.81M
PE Ratio	112.20
Forward PE	84.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	91,518
Average Volume	126,757
Open	442.20
Previous Close	444.80
Day's Range	432.70 - 447.90
52-Week Range	327.00 - 568.00
Beta	n/a
RSI	39.38
Earnings Date	May 26, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.